As for the rest, just wait.

Mainly waiting for Professor Witten's reply.

If he is sure that there are no problems, then there will basically be no problems with the paper, and then he can choose a journal for submission and publication.

As for which journal to submit the manuscript to, Xu Chuan fell into deep thought.

This is the first time in his life that he has truly demonstrated his ability in physics. Naturally, he must choose the most suitable candidate for the paper and journal.

There are many top journals in the physics world, such as "Physical Review Letters", "Applied Physics Letters", "nature-physics", "sce", "Physical Reviews a/b", "Progress in Physics", etc.

But to be honest, it would be impossible to publish these top physics journals in one of the four major journals like mathematics journals.

Except for a few of these physics journals, which cover all categories of physics, the others basically have their own focus, and it feels like a hundred flowers are blooming.

In today's physics world, in terms of the reputation and popularity of current magazines, "Nature" and "SCE" are the highest, while PRL (Physical Review Letters) is relatively lower.

Therefore, ordinary scientific researchers usually have a pre-judgment about the general research results they obtain. If they think it is suitable for publication in Nature or SCE, they generally will not submit it to PRL first.

If you are a scientific researcher in China, you will often submit your paper to Nature first. If your paper is rejected, you will then submit it to SCE, and finally you will choose PRL (Physical Review Letters).

But to be honest, Xu Chuan doesn't like the journal "Nature" very much, even though this top journal has a very great reputation and a high impact factor.

Because it has been exposed many times that there have been incidents of "academic misconduct" in papers.

The most serious thing, and the one that has been widely known to the whole people, is the falsification of two Nobel Prize-level medical papers.

The first time was the famous falsification of the universal cell paper by Obokata Haruko of Kojima Kununi.

The other time was the possibility of academic misconduct in more than 20 papers published by neuroscientist Sylvain Lesne of the University of Minnesota in the United States, which would only be revealed later.

This includes a groundbreaking paper published by Lesne in Nature in 2006, a groundbreaking paper that has been cited more than 2,300 times.

This chapter is not over, please click on the next page to continue reading! This groundbreaking paper involves the most cited Alzheimer's disease (commonly known as "senile dementia") research in the 21st century.

In this paper, Lesne introduced a substance discovered in the laboratory-aβ* 56.

This discovery caused a stir in the field of AD research at the time - as a specific aβ oligomer, there is a link between aβ*56 and cognitive decline, which pointed out a way for drug research in the field of Alzheimer's disease

.

Since then, the medical community has devoted a lot of attention to this aspect.

Since then, NIH support for the "Amyloid, Oligomers, and Alzheimer's Disease" research has risen from zero to $287 million in 2021.

However, outside of Ashe and Lesne's labs, few subsequent publications have mentioned aβ* 56. Likewise, other scientists who study aβ proteins have said they are not sure whether aβ* 56 actually exists.

According to Science, many Alzheimer's researchers have tried but been unable to replicate these findings about aβ*56.

One of them was Dennis Selkoe of Brigham and Women's Hospital, a leading advocate of the "amyloid hypothesis." In 2008, Selkoe reported that Aβ* 56 could not be found in human cortical extracts and brain crest fluid.

Then Nature's old rival Science magazine spent six months conducting an in-depth investigation of these papers with well-known independent image analysts and top Alzheimer's disease researchers.

.

Eventually, it was discovered that more than hundreds of pictures in these papers contained suspicious traces.

Lisabeth Bick, a molecular biologist and well-known academic counterfeiter, said: "These images appear to be composite images by the author by piecing together parts of images from different experiments."

"Perhaps the authors obtained experimental results that may not have been the expected results and then changed these data to better fit a hypothetical image."

Both serious fraud incidents had a huge impact on the medical community, wasting countless financial and material resources, and the energy of a large number of scientific researchers.

This made Xu Chuan seriously doubt whether Nature's impurity review was as good as they said.

Although "Nature" is indeed one of the oldest scientific journals in the world, it has made huge contributions to the development of science.

But it is undeniable that they have successively failed in their review work.
Chapter completed!